Cancer and ageing: a nexus at several levels
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Cancer is largely a disease of older people. With the relatively recent expansive growth within the geriatric population, a number of pressing biological and clinical questions that currently remain unanswered need to be addressed. These include what effect age itself has on the development or growth of cancer, and what are the benefits and risks of cancer prevention and treatment for the older person? New insights into the underlying biological processes of ageing provide a frame of reference for addressing these and other related questions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cancer, like the age-related degenerative diseases, increases in incidence with nearly exponential kinetics beginning at approximately the mid-point of the life span (in species that are susceptible to this disease) (3, 6, 7).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [6]
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 1×
“In addition, the CHS classification could prove useful for categorizing older individuals that are involved in clinical trials of cancer treatmen”
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850 · cited 1×
“12 ), with more than 50% of lung cancer deaths occurring in those over 70 (Ref”
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., & Ishitsuka, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00058-6 · Cited by 1,240 · cited 1×
“Capecitabine is a pro-drug of fluorouracil that usually spares normal tissues as it is preferentially activated in neoplastic tissue”
Efficacy of screening mammography. A meta-analysis
Kerlikowske, K. M. (1995) · JAMA · doi:10.1001/jama.273.2.149 · Cited by 1,131 · cited 1×
“Although all randomized, controlled studies of mammography screening had an upper age limit of 65 or 70 year”
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031 · cited 1×
“Because of their recently established greater efficacy and better safety profiles, aromatase inhibitors that suppress oestrogen synthesis have largely replaced SERMs in the management of breast cancer in the adjuvant and metastatic setting”
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Research works printed but not linked: 3
- Hammerman, D. Comprehensive Geriatric Oncology (eds Balducci, L., Lyman, G. H., Ershler, W. B. & Extermann, M.) 250–259 (Taylor and Francis, London, 2004).
- Extermann, M. Comprehensive Geriatric Oncology (eds Balducci, L., Lyman, G. H., Ershler, W. B. & Extermann, M.) 223–232 (Taylor and Francis, London, 2004).
- Scalliet, P. & Pignon, T. Comprehensive Geriatric Oncology (eds Balducci, L., Lyman, G. H., Ershler, W. B. & Extermann, M.) 453–462 (Taylor and Francis. London 2004).
Cited by
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
“It is important to remember that cancer is primarily an age-related disease (Campisi, 2003; Balducci and Ershler, 2005).”
Cellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421
“In humans, cancer incidence rises with approximately exponential kinetics after about 50 years of age [3, 4].”
Two faces of p53: aging and tumor suppression
Rodier, F., Campisi, J., & Bhaumik, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm744 · Cited by 398
“Cancer is a major age-related disease in mice, humans and many other mammals (7).”
GRØNBÆK, K., HOTHER, C., & JONES, P. A. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_636.xml.x · Cited by 366
“The molecular events underlying the adverse effects of aging are most probably multifaceted (58, 59); however, altered DNA methylation patterns in aging tissues may be a key contributor (60).”
How ageing processes influence cancer
de Magalhães, J. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3497 · Cited by 367
Ramalingam, S. S., Dahlberg, S. E., Langer, C. J., Gray, R., Belani, C. P., Brahmer, J. R., Sandler, A. B., Schiller, J. H., & Johnson, D. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1144 · Cited by 348
Chemotherapy and Dietary Phytochemical Agents
Sak, K. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/282570 · Cited by 310
“It is important to bear in mind that, in general, older cancer patients are more susceptible to treatment-related complications than younger individuals [56].”
Ageing, oxidative stress and cancer: paradigms in parallax
Benz, C. C., & Yau, C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2522 · Cited by 278
Age‐related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF‐like growth factor
Choi, N., Kim, J., Yang, D., Kim, Y., & Yoo, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00380.x · Cited by 260
“Knowledge of the underlying regulatory mechanisms associated with age-related changes in ISCs is vitally important to our understanding of cancer development, as cancer is considered an age-related disease (reviewed in Krtolica & Campisi, 2002; Balducci & Ershler, 2005).”
The circadian clock in cancer development and therapy
Fu, L., & Kettner, N. M. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396971-2.00009-9 · Cited by 251
Age-induced accumulation of methylmalonic acid promotes tumour progression
Gomes, A. P., Ilter, D., Low, V., Endress, J. E., Fernández-García, J., Rosenzweig, A., Schild, T., Broekaert, D., Ahmed, A., Planque, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2630-0 · Cited by 244
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Jung‐Hynes, B., Reiter, R. J., & Ahmad, N. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00729.x · Cited by 233
“Further, a number of cancer types such as acute myeloid leukemia, breast, nonsmall cell lung cancer, and ovarian cancers tend to become resistant to chemotherapy and/or more indolent with increasing age [48].”
Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
Brauning, A., Rae, M., Zhu, G., Fulton, E., Admasu, T. D., Stolzing, A., & Sharma, A. (2022) · Cells · doi:10.3390/cells11061017 · Cited by 215
“For example, adult cancer incidence and mortality for all-site invasive cancers and for many individual cancer types rise progressively with age [100,101] and the decline in NK cell function with age is implicated in this increased risk [102].”
Lin, L., Yan, L., Liu, Y., Yuan, F., Li, H., & Ni, J. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0783-9 · Cited by 212
“Due to population growth and aging, the morbidity and mortality associated with cancer are rapidly increasing globally, reflecting the changes in the prevalence and distribution of major risk factors of cancer [1, 2].”
Darwinian medicine: a case for cancer
Greaves, M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2071 · Cited by 180
Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy
Wang, Y., Ji, P., Liu, J., Broaddus, R. R., Xue, F., & Zhang, W. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-8 · Cited by 179
“associated with the global economy, cancer has emerged as the top threat to human life worldwide [1,2].”
Derhovanessian, E., Solana, R., Larbi, A., & Pawelec, G. (2008) · Immunity & Ageing · doi:10.1186/1742-4933-5-11 · Cited by 169
“In contrast, tumors with weak immunogenicity, like B16 melanoma, were more aggressive and grew better in young animals compared to old (reviewed in [112]).”
Management of cancer in the elderly.
Balducci, L. (2006) · PubMed · Cited by 143
Self-citationHead and neck cancer in the elderly: An overview on the treatment modalities
Syrigos, K., Karachalios, D., Karapanagiotou, E. M., Nutting, C. M., Manolopoulos, L., & Harrington, K. J. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.002 · Cited by 155
Mirsoian, A., Bouchlaka, M. N., Sckisel, G. D., Chen, M., Pai, C.-C. S., Maverakis, E., Spencer, R. G., Fishbein, K. W., Siddiqui, S., Monjazeb, A. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140116 · Cited by 138
“Cancer has been considered a disease of aging, with persons over 65 accounting for over 60% of newly diagnosed malignancies (Balducci and Ershler, 2005).”
de Pablos, R. M., Espinosa-Oliva, A. M., Hornedo-Ortega, R., Cano, M., & Arguelles, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.005 · Cited by 135
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Wiley, C. D., Schaum, N., Alimirah, F., Lopez-Dominguez, J. A., Orjalo, A. V., Scott, G., Desprez, P.-Y., Benz, C., Davalos, A. R., & Campisi, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20000-4 · Cited by 124
Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Mendoza‐Marí, Y., Bringas-Vega, M. L., Berlanga-Saez, J. O., Herrera, D. G. D. B., Martínez-Jiménez, I., Hernandez-Gutierrez, S., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573032 · Cited by 131
“Surprisingly, two well-reputed growth factors implicated in wound fibro-angiogenic response: transforming growth factor β1 (TGF-β1) and vascular endothelial growth factor (VEGF), are involved in the remote transformation of healthy to senescent cells (105, 106).”
Senescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112
“Age is the single most significant risk factor for developing cancer, and the vast majority of malignant tumors that are treated in clinics today occur in older patients [4, 5].”
Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics
Berghe, W. V., Ndlovu, ’. N., Hoya-Arias, R., Dijsselbloem, N., Gerlo, S., & Haegeman, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.012 · Cited by 120
Anisimov, V. N. (2007) · Cancer Control · doi:10.1177/107327480701400104 · Cited by 108
The future burden of cancer in England: incidence and numbers of new patients in 2020
Møller, H., Fairley, L., Coupland, V. H., Okello, C., Green, M., Forman, D., Møller, B., & Bray, F. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603746 · Cited by 108
“…should give consideration to the special circumstances of this group, including increased surgical mortality, toxicity of chemotherapy, treatment-related complications, general comorbidity, and special needs for supportive and palliative care (Edwards et al, 2002; Balducci and Ershler, 2005).”
Fatigue and Functional Dependence in Older Cancer Patients
Luciani, A., Jacobsen, P. B., Extermann, M., Foa, P., Marussi, D., Overcash, J. A., & Balducci, L. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31816d915f · Cited by 108
“Cancer is mainly a disease of the older aged person.(1,2) Aging is associated with a progressive decline in the functional reserve of multiple organs and systems, increased prevalence of comorbidities, and with fading personal, economical, and social resources.”
Self-citationThe evolving concept of tumor microenvironments
Laconi, E. (2007) · BioEssays · doi:10.1002/bies.20606 · Cited by 98
Montroni, I., Rostoft, S., Spinelli, A., van Leeuwen, B. L., Ercolani, G., Saur, N. M., Jaklitsch, M. T., Somasundar, P. S., Carino, N. D. L., Ghignone, F., et al. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.06.017 · Cited by 104
The cell-line-derived subcutaneous tumor model in preclinical cancer research
Stribbling, S. M., & Ryan, A. J. (2022) · Nature Protocols · doi:10.1038/s41596-022-00709-3 · Cited by 112
Bonafè, M., Storci, G., & Franceschi, C. (2012) · BioEssays · doi:10.1002/bies.201100104 · Cited by 94
Aspirin in the Prevention of Colorectal Neoplasia
Drew, D. A., & Chan, A. T. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-060319-120913 · Cited by 97
“These changes include attenuated DNA repair, accumulation of oxidative damage, impaired proteostasis, defective immune surveillance, increased numbers of stem cell divisions (77, 78), and promotion of tumor growth and metastasis (75, 79).”
West, J., Beck, S., Wang, X., & Teschendorff, A. E. (2013) · Scientific Reports · doi:10.1038/srep01630 · Cited by 89
Rostoft, S., Jordhøy, M. S., Nesbakken, A., Skovlund, E., Bakka, A. O., Johannessen, H., & Wyller, T. B. (2010) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2010.06.001 · Cited by 86
Noreen, F., Röösli, M., Gaj, P., Pietrzak, J., Weis, S., Urfer, P., Regula, J., Schär, P., & Truninger, K. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju161 · Cited by 82
“Hypermethylation at promoters of tumor suppressor genes is a hallmark of colorectal cancer (CRC), for which age is a major risk factor (5,6).”
Applying ecological and evolutionary theory to cancer: a long and winding road
Thomas, F., Fisher, D., Fort, P., Marie, J., Daoust, S., Roche, B., Grunau, C., Cosseau, C., Mitta, G., Baghdiguian, S., et al. (2013) · Evolutionary Applications · doi:10.1111/eva.12021 · Cited by 81
“For instance, as for genes reducing survival in general, selection is unlikely to strongly counter-select oncogenes when their negative effects occur after reproduction (Frank 2004, 2005; Balducci and Ershler 2005).”
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
Yau, C. S. F., Fedele, V., Roydasgupta, R., Fridlyand, J., Hubbard, A., Gray, J. W., Chew, K., Dairkee, S. H., Moore, D. H., Schittulli, F., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1765 · Cited by 83
Vallejo, A. N. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.01.005 · Cited by 89
Cancer Burden in Latin America and the Caribbean
Paula Curado, M., & Bezerra de Souza, D. L. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2014.09.009 · Cited by 78
Cancer and Age: General Considerations
Hoffe, S. E., & Balducci, L. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.09.001 · Cited by 87
Self-citationPrelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion
de la Rosa, J., Freije, J. M. P., Cabanillas, R., Osorio, F. G., Fraga, M. F., Fernández-García, M. S., Rad, R., Fanjul, V., Ugalde, A. P., Liang, Q., et al. (2013) · Nature Communications · doi:10.1038/ncomms3268 · Cited by 77
Anemia of Aging: The Role of Chronic Inflammation and Cancer
Ferrucci, L., & Balducci, L. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.06.001 · Cited by 80
Self-citationCellular Senescence and Lung Function during Aging. Yin and Yang
Campisi, J. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-703aw · Cited by 74
Relationships between cancer and aging: a multilevel approach
Anisimov, V. N., Sikora, E., & Pawelec, G. (2009) · Biogerontology · doi:10.1007/s10522-008-9209-8 · Cited by 77
“Aging is associated with a number of events at the molecular, cellular and physiological levels that influence carcinogenesis and subsequent cancer growth (Anisimov 2003a, b, c; Balducci and Ershler 2005) such that individualized treatment of each patient’s tumor will require taking this into account.”
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis
Zhuang, X., Wang, Q., Joost, S., Ferrena, A., Humphreys, D. T., Li, Z., Blum, M., Krause, K., Ding, S., Landais, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08285-0 · Cited by 81
Jung-Hynes, B., & Ahmad, N. (2009) · The FASEB Journal · doi:10.1096/fj.09-129148 · Cited by 67
“Point mutations, genetic instability, DNA hypermethylation, and DNA adduct formation are critical molecular events that may lead to the activation of oncogenes and suppression of tumor suppressor genes (20, 22, 23).”
Galvão, F., Grokoski, K. C., da Silva, B. B., Lamers, M. L., & Siqueira, I. R. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.007 · Cited by 74
Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Shin, E., Bak, S. H., Park, T., Kim, J.-W., Yoon, S. R., Jung, H., & Noh, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192907 · Cited by 79
Eyman, D., Damodarasamy, M., Plymate, S. R., & Reed, M. J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21776 · Cited by 63
“DOI: 10.1002/jcp.21776 There is a close correlation between host age and the prevalence of both benign (prostatic hyperplasia) and malignant (cancer) prostate disease (Balducci and Ershler, 2005; Untergasser et al., 2005; Nelen, 2007).”
InfluentialDigital Ischemia Associated With Cancer
le Besnerais, M., Miranda, S., Cailleux, N., Girszyn, N., Marié, I., Levesque, H., & Benhamou, Y. (2014) · Medicine · doi:10.1097/md.0000000000000047 · Cited by 63
“Firstly, we observe that patients with DIAC were older than patients without cancer.(11,33,34) This finding confirms that paraneoplastic syndrome usually occurs in older patients.”
Muscoloskeletal aging, sarcopenia and cancer
Colloca, G. A., Capua, B. D., Bellieni, A., Cesari, M., Marzetti, E., Valentini, V., & Calvani, R. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.11.007 · Cited by 71
Brain, E. G. C., Mertens, C., Girre, V., Rousseau, F., Blot, E., Abadie, S., Uwer, L., Bourbouloux, E., Praagh-Doreau, I. V., Mourey, L., et al. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.10.003 · Cited by 56
Absence of cytoglobin promotes multiple organ abnormalities in aged mice
Thủy, L. T. T., Thuy, T. T. V., Matsumoto, Y., Hai, H., Ikura, Y., Yoshizato, K., & Kawada, N. (2016) · Scientific Reports · doi:10.1038/srep24990 · Cited by 54
Liao, P., Ostrom, Q. T., Stetson, L. C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy003 · Cited by 55
Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Donehower, L. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001081 · Cited by 55
The effects of aging on tumor growth and angiogenesis are tumor‐cell dependent
Reed, M. J., Karres, N., Eyman, D., Cruz, A., Brekken, R. A., & Plymate, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22351 · Cited by 53
Meoni, G., Cecere, F. L., Lucherini, E., & Costanzo, F. D. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.04.005 · Cited by 53
Studying Cancer Treatment in the Elderly Patient Population
Balducci, L. (2014) · Cancer Control · doi:10.1177/107327481402100306 · Cited by 58
Self-citationImmunosenescence: limitations of natural killer cell-based cancer immunotherapy
Tarazona, R., Sánchez-Correa, B., Casas-Avilés, I., Campos, C., Pera, A., Morgado, S., López-Sejas, N., Hassouneh, F., Bergua, J., Arcos, M. J., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1882-x · Cited by 56
“Age-related changes have been also observed in ovarian carcinoma and non-Hodgkin lymphoma showing decreased response to chemotherapy in elderly patients [4].”
Langer, C. J., Socinski, M. A., Patel, J. D., Sandler, A. B., Schiller, J. H., Leon, L., Hazard, S. J., & Ramalingam, S. S. (2015) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000163 · Cited by 50
“For instance, age-related decreases in renal function, immune response, and bone marrow regeneration may impact tolerance and response to therapy.(23) The presence of comorbidities, such as respiratory or cardiovascular disorders, may also influence clinical outcomes and can exacerbate treatment-related toxicities, ul…”
Control of Advanced Cancer: The Road to Chronicity
Lage, A., & Crombet, T. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8030683 · Cited by 46
“diagnosis is increasing and it has been projected that 70% of all neoplasms will occur in individuals of 65 years and older by 2030 [5].”
Geriatric Oncology: An Overview of Progresses and Challenges
Extermann, M. (2010) · Cancer Research and Treatment · doi:10.4143/crt.2010.42.2.61 · Cited by 56
“Several laboratory and translational studies have explored the modification of the biology and behavior of cancer with age, as well as concepts such as the antagonistic pleiotropism of aging and cancer (64-67).”
Barajas-Gómez, B. A., Rosas‐Carrasco, Ó., Morales-Rosales, S. L., Pedraza-Vázquez, G., González‐Puertos, V. Y., Juárez‐Cedillo, T., García, J. A., López‐Díazguerrero, N. E., Damián‐Matsumura, P., Königsberg, M., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.12.001 · Cited by 53
Al-Ajmi, K., Lophatananon, A., Ollier, W., & Muir, K. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201097 · Cited by 49
Moiseeva, O., Xavier-Deschênes-Simard, Pollak, M., & Ferbeyre, G. (2013) · Aging · doi:10.18632/aging.100556 · Cited by 46
Global burden prediction of gastric cancer during demographic transition from 2020 to 2040
Yan, C., Shan, F., Ying, X., & Li, Z. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002626 · Cited by 51
“As cancer is a disease of ageing, the median age for cancer diagnosis in developed countries is approaching 70 years of age, and nearly 70% of all cancer cases are expected to occur in individuals aged 65 and above by 2030.([4]) Thus, the global burden of cancer will be significantly increased due to the growing geria…”
Campisi, J., & Sedivy, J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln073 · Cited by 43
Towards a systemic paradigm in carcinogenesis: linking epigenetics and genetics
Burgio, E., & Migliore, L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3804-3 · Cited by 50
“The SMT also interprets the increase in human cancers in post-industrial societies, characterized by a significant lengthening of lifespan: it assumes that DNA gradually destabilizes with age, due to an accumulation of oxidative damage [25–28].”
Bensken, W. P., Schiltz, N. K., Warner, D. F., Kim, D. H., Wei, M. Y., Quiñones, A. R., Ho, V. P., Kelley, A. S., Owusu, C., Kent, E. E., et al. (2022) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2022.06.011 · Cited by 49
Klement, H., Croix, B. S., Milsom, C., May, L. L., Guo, Q., Yu, J., Klement, P., & Rak, J. W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070298 · Cited by 41
Pentheroudakis, G. E., Fountzilas, G., Kalofonos, H. P., Golfinopoulos, V. S., Aravantinos, G., Bafaloukos, D. I., Papakostas, P., Pectasides, D. G., Christodoulou, C., Syrigos, K., et al. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.003 · Cited by 43
“Cancer incidence is rising with age in most solid tumours, phenomenon attributed to prolonged host exposure to nvironmental carcinogens, accumulating genetic/epigenetic amage to normal tissues and increased susceptibility of geing cells to toxic injuries [1].”
Alblas, M., Velt, K., Pashayan, N., Widschwendter, M., Steyerberg, E. W., & Vergouwe, Y. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.03.023 · Cited by 50
“The relation between age and the development of several types of cancer has been most extensively described (DePinho, 2000; Balducci and Ershler, 2005; Anisimov, 2003).”
Piperlongumine decreases cognitive impairment and improves hippocampal function in aged mice
Go, J., Park, T., Han, G., Park, H., Ryu, Y., Kim, Y., Hwang, J., Choi, D., Noh, J., Hwang, D., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3782 · Cited by 39
“…kill multiple types of cancer cells through the targeting of the stress response to reactive oxygen species (ROS) (14,36). diagnosis with certain tumours, such as age-related degenerative diseases, increases with age and the molecular alterations that occur in aging can favour carcinogenesis (37).”
All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer
Chesney, T. R., Coburn, N. G., Mahar, A. L., Davis, L., Zuk, V., Zhao, H., Hsu, A. T., Wright, F. C., Haas, B., Hallet, J. I., et al. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.1425 · Cited by 44
Aging is associated with increased clonogenic potential in rat liver in vivo
Pasciu, D., Montisci, S., Greco, M., Doratiotto, S., Pitzalis, S., Pani, P., Laconi, S., & Laconi, E. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00230.x · Cited by 38
“Several factors have been implicated, including the progressive accumulation of critical DNA alterations in specific target cells and a decline in the immunological surveillance (Balducci & Ershler, 2005).”
Moseholm, E., & Lindhardt, B. Ø. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.08.003 · Cited by 40
Clinical analysis of multiple primary malignancies in the elderly
Luciani, A., Ascione, G., Marussi, D., Oldani, S., Caldiera, S., Bozzoni, S., Codecà, C., Zonato, S., Ferrari, D., & Foa, P. (2008) · Medical Oncology · doi:10.1007/s12032-008-9075-x · Cited by 37
“Cancer incidence raises progressively during life span [1], and it is estimated that by the year 2030 almost 70% of all neoplasms will occur in people over 65 years [2].”
Outcomes of acute pulmonary embolism in hospitalized patients with cancer
Shalaby, K., Kahn, A. M., Silver, E., Kim, M. J., Balakumaran, K., & Kim, A. S. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01808-9 · Cited by 34
“Cancer is largely a disease of older age, and the geriatric population has expanded in the recent decades [9].”
Age-related upregulation of Drosophila caudal gene via NF-κB in the adult posterior midgut
Choi, Y.-J., Hwang, M.-S., Park, J., Bae, S., Kim, Y.-S., & Yoo, M. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.008 · Cited by 39
Cancer chemotherapy in the older cancer patient
Carreca, I. U., & Balducci, L. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.08.006 · Cited by 33
Self-citationPreventive Evolutionary Medicine of Cancers
Hochberg, M., Thomas, F., Assénat, E., & Hibner, U. (2012) · Evolutionary Applications · doi:10.1111/eva.12033 · Cited by 33
“Evolutionary theory predicts the clinically observed increase of cancer incidence with age (e.g. Balducci and Ershler 2005).”
Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
Liu, Y., Hu, X., Liu, S., Zhou, S., Chen, Z., & Jin, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.783860 · Cited by 33
Supportive care in elderly cancer patients
Balducci, L. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832b4f25 · Cited by 35
Self-citationLuciani, A., Dottorini, L., Battisti, N. M. L., Bertuzzi, C., Caldiera, S., Floriani, I., Zonato, S., Ferrari, D., & Foa, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds471 · Cited by 33
“As >70% of the total number of cancer deaths in the United States occur in people ≥65 years of age, cancer is largely a disease affecting older people [1].”
Geriatric oncology, general practitioners and specialists: Current opinions and unmet needs
Kurtz, J., Heitz, D., Enderlin, P., Imbert, F., Nehme-Schuster, H., Bergerat, J., & Dufour, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.03.002 · Cited by 29
“Treatment decisions in geritric oncology rely on several issues, including the lethality f the disease; the life expectancy without cancer sympoms; the treatment anticipated tolerance and its impact on hysical/cognitive status of the patient [10].”
Higashiguchi, M., Murakami, H., Hirofumi, H., Kobayashi, S., Takahama, S., Iwagami, Y., Yamada, D., Tomimaru, Y., Noda, T., Gotoh, K., et al. (2023) · Oncology Reports · doi:10.3892/or.2023.8535 · Cited by 30
“In general, malignancy risk increases with aging (11,12), and numerous studies have focused on the relationship between cellular senescence and malignant tumors (12,13).”
Debra-Mediated Ci Degradation Controls Tissue Homeostasis in Drosophila Adult Midgut
Li, Z., Guo, Y., Han, L., Zhang, Y., Shi, L. S., Huang, X., & Lin, X. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.12.011 · Cited by 32
“This leads to the hypothesis that stem cell aging may be responsible for age-associated tissue function deterioration and agerelated degenerative diseases (Balducci and Ershler, 2005; Bell and Van Zant, 2004; Krtolica, 2005; Van Zant and Liang, 2003).”
Damodarasamy, M., Vernon, R. B., Karres, N., Chang, C. H., Bianchi-Frias, D., Nelson, P. S., & Reed, M. J. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp202 · Cited by 28
“This type of investigation is an area of high gerontological relevance (58,59) and is presently being examined in our laboratory.”
Okumura, T., Takeda, K., Taniguchi, K., & Adachi‐Yamada, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089387 · Cited by 30
“There is much evidence suggesting that aging creates conditions conducive to the incidence of neoplastic diseases such as cancer [56].”
Age‐related properties of the tumour vasculature in renal cell carcinoma
Meehan, B., Appu, S., Croix, B. S., Rak‐Poznanska, K., Klotz, L., & Rak, J. W. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09569.x · Cited by 30
Vascular determinants of cancer stem cell dormancy—do age and coagulation system play a role?
Rak, J. W., Milsom, C., & Yu, J. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.01058.x · Cited by 26
“breast cancer (12)), has been that their occurrence in older patients may be associated with a less aggressive behaviour (56).”
Roma, M. F. B., Garção, N. I. B., Covinsky, K. E., & Aliberti, M. J. R. (2022) · Geriatrics Gerontology and Aging · doi:10.53886/gga.e0220031 · Cited by 30
Kalra, R. S., Chaudhary, A., Omar, A., Cheung, C., Garg, S., Kaul, S. C., & Wadhwa, R. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01088-y · Cited by 22
Multiple Myeloma in the Very Old: An IASIA Conference Report
Tuchman, S. A., Shapiro, G. R., Ershler, W. B., Badros, A. Z., Cohen, H. J., Dispenzieri, A. A., Flores, I. Q., Kanapuru, B., Jurivich, D. A., Longo, D. L., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju067 · Cited by 22
“In acute myeloid leukemia, for example, curative treatment includes highly intensive chemotherapy regimens such as cytarabine and an anthracycline—an approach for which most older patients are not candidates (29).”
Self-citationChesney, T. R., Haas, B., Coburn, N. G., Mahar, A. L., Davis, L., Zuk, V., Zhao, H., Wright, F. C., Hsu, A. T., & Hallet, J. I. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.09.009 · Cited by 21
Hallet, J. I., Tillman, B., Zuckerman, J., Guttman, M. P., Chesney, T. R., Mahar, A. L., Chan, W. C., Coburn, N. G., Haas, B., & _, _. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7052 · Cited by 23
Non-Coding RNA Molecules Connect Calorie Restriction and Lifespan
Abraham, K. J., Ostrowski, L., & Mekhail, K. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.020 · Cited by 22
Hu, C., Ye, M., Bai, J., Liu, P., Lu, F., Chen, J., Yu, P., Chen, T., Shi, X., & Tang, Q. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02973-z · Cited by 21
“The risk of cancer incidence rate and related mortality among people over 65 years of age is greatly increased [6, 7].”
Metadata
- Authors
- Balducci, L., & Ershler, W. B.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Balducci, Lodovico
- Ershler, William B.
- Venue
- Nature Reviews Cancer
- Published
- 2005-08
- Volume
- 5
- Issue
- 8
- Pages
- 655-662
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1593300855
- Cited by
- 250
- References
- 78
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 7 · 2020: 14 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 10 · 2015: 10 · 2014: 15 · 2013: 18 · 2012: 21
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- geriatric oncology, aging, age-related cancer risk, cancer treatment in the elderly
- MeSH terms
- Aging, Humans, Neoplasms, Socioeconomic Factors, Geriatric Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.